ArticleJournal of medical case reports2026
Primary nasopharyngeal Kaposi's sarcoma without cutaneous manifestations: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundKaposi's sarcoma (KS) is a neoplastic lymphovascular disorder. It typically appears on the skin of the upper and lower extremities, but can also occur on the mucosal surfaces of the head and neck. The most common site reported for head and neck injuries is within the oral cavity, particularly on the palate, and other mucosal sites, such as the nasopharyngeal area. Moreover, involvement of the nasopharynx without skin involvement is even rarer. CASE PRESENTATION: Here, we present a rare case of HIV associated/epidemic KS in a 30-year-old man of African origin, where the primary manifestation was in the nasopharyngeal (NP) area. After the diagnosis, the patient began chemotherapy with the ABV regimen and low-dose radiotherapy, which resulted in clinical improvement and no recurrence during the 6-year follow-up period.
conclusionWe have reported the first case of primary nasopharyngeal epidemic Kaposi's sarcoma (KS) in SSA, which presented at an unusual location with atypical features on routine hematoxylin and eosin (H&E) examination and without cutaneous manifestations. The unusually high median survival for this poor-risk epidemic nasopharyngeal KS points to the need to study the natural history of non-cutaneous KS in comparison to other forms of KS that have demonstrated a very dismal survival. This case is highly representative of the complexity of HIV management. The authors aim to bring awareness of the KS's unusual locations and diagnosis challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.